TF
JAZZ icon

Tompkins Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Tompkins Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.79K Hold
25
– – ﹤0.01% 506
2026
Q2 		$6.02K Hold
25
– – ﹤0.01% 488
2026
Q1 		$4.73K Hold
25
– – ﹤0.01% 497
2025
Q4 		$4.25K Hold
25
– – ﹤0.01% 495
2025
Q3 		$3.29K Hold
25
– – ﹤0.01% 494
2025
Q2 		$2.65K Hold
25
– – ﹤0.01% 499
2025
Q1 		$3.1K Sell
25
-25
-50% -$3.26K ﹤0.01% 511
2024
Q4 		$6.16K Hold
50
– – ﹤0.01% 455
2024
Q3 		$5.57K Sell
50
-100
-67% -$11K ﹤0.01% 509
2024
Q2 		$16K Buy
+150
New +$16.5K ﹤0.01% 452
2021
Q1 		– Sell
-5
Closed -$1K – 472
2020
Q4 		$1K Buy
+5
New +$745 ﹤0.01% 465

Other funds holding JAZZ

ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return

Tompkins Financial's JAZZ Position: Q3 2026 in Review

Tompkins Financial held its Jazz Pharmaceuticals (JAZZ) position steady in Q3 2026 at 25 shares worth $5.79K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Tompkins Financial first reported a position in JAZZ in Q4 2020 and has held it in 11 quarters since. The position peaked at $16K in Q2 2024. 21 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Tompkins Financial held 25 shares of Jazz Pharmaceuticals worth $5.79K as of Q3 2026.
  • Tompkins Financial left its Jazz Pharmaceuticals share count unchanged in Q3 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Tompkins Financial's portfolio in Q3 2026, its #506 holding.
  • Tompkins Financial first reported a position in Jazz Pharmaceuticals in Q4 2020 and has held it in 11 quarters since.
  • Tompkins Financial's Jazz Pharmaceuticals position peaked at $16K in Q2 2024.
  • 21 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Tompkins Financial's 13F filing for Q3 2026, filed 5 Oct 2026.